본문 바로가기
KERD
논문KCI 등재

허혈성 뇌졸중 환자에서 몸무게에 기반한 환자 맞춤형 경정맥 헤파린 투여 지침의 유용성

Usefulness of a Weighted-based, Patient-Specific Nomogram for Intravenous Heparin Therapy in Ischemic Stroke Patients

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류신경과학

초록

Abstract

Background: Despite the lack of supporting evidence, intravenous heparin is still given frequently in the treatment of cerebral ischemia. However, there is only one study for the use of heparin nomogram in ischemic stroke or TIA. We evaluated the usefulness of a patient-specific, as well as weight-based, nomogram for the intravenous heparin in patients with ischemic stroke or TIA. Methods: From Sep. 2004 to Sep. 2005, we recruited ischemic stroke patients treated according to the specifically designed heparin nomogram. The therapeutic range (TR) of activated partial thromboplastin time (aPTT) and dose adjustment were specified as a ratio of each patient’s baseline aPTT. The first time to achieve TR (TR-time), to exceed therapeutic threshold (TE-time) and the fraction of time in TR (total time in TR/total time of heparin use, %) were analyzed. Results: A total of 45 patients were included. The mean fraction of time in TR was 72.7±14.4%. Although TR-time and TE-time did not differ according to the use of bolus injection, the fraction of first aPTT at 6 hours after start of infusion in TR was higher with bolus than without bolus (84.8 vs. 58.3, p<0.05). Conclusions: Our nomogram could achieve and maintain therapeutic heparin anticoagulation effectively. Initial bolus injection may be better to achieve therapeutic anticoagulation more rapidly. KeyWords:Anticoagulation, Heparin, Weight-based nomogram

참고문헌 (23)

  1. "Use of intravenous heparin by North American neurologists: do the data matter?", 33, pp.1574~1577 (2002)
  2. "The Usage of Intravenous Heparin in Acute Ischemic Stroke in 10 Teaching Hospitals", 23, pp.446~450 (2005)
  3. "Immediate anticoagulation for acute stroke in atrial fibrillation: no", 37, pp.3054~3055 (2006)
  4. "Immediate anticoagulation for acute stroke in atrial fibrillation: yes", 37, pp.3052~3053 (2006)
  5. "Immediate anticoagulation for acute stroke in atrial fibrillation: no, but", 37, pp.3056~ (2006)
  6. "Sims GE. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration. Thromb Res 1976", pp.575~583
  7. "Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993", pp.104~109
  8. "Wells BW. Ultra-low dose intravenous heparin in the prevention of postoperative deep- vein thrombosis. Lancet 1980", pp.891~894
  9. "CHoi IS. Monitoring of Heparin Treatment in Acute Cerebral Infarction. J Korean Neurol Assoc 1992", pp.119~125
  10. "Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991", pp.333~337
  11. "Srinivas S. The weight-based heparin dosing nomogram compared with a", pp.874~881
  12. "Heparin administration via nomogram versus a standard approach in venous and arterial thromboembolic disease", 1, pp.97~101 (1996)
  13. "Developing and testing a system to improve the quality of heparin anticoagulation in patients with acute cardiac syndromes", 82, pp.574~579 (1998)
  14. "Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke", 33, pp.670~674 (2002)
  15. "Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation", 16, pp.1076~1084 (1996)
  16. "Immediate anticoagulation of embolic stroke", pp.779~789
  17. "Immediate anticoagulation of embolic stroke", pp.668~676
  18. "a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group", 349, pp.1569~1581 (1997)
  19. "Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial", 32, pp.2333~2337 (2001)
  20. "variables related to disposition and dosage. Clin Pharmacol Ther 1981", pp.387~393
  21. "et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992", pp.1589~1595
  22. "Fuster V. Guide to anticoagulant therapy. Part 1", pp.1449~1468
  23. "Raskob G. Hemorrhagic complications of anticoagulant treatment. Chest 1992", pp.352~363

관련 논문AI추천

급성기 허혈성 뇌졸중에서 10개 교육병원의 정맥주사 헤파린 이용 실태권영대, 박기정, 안태범, 윤성상, 장대일, 장혜영, 정경천, 허성혁대한신경과학회 · 대한신경과학회지2005 · 제23권 제4호2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack김철호, 배희준, 정근화, 정혜선, 허지회, Byung-Chul Lee, Byung-Woo Yoon, Dae Hyun Kim, Hong-Kyun Park, Jay Chol Choi, Jong S. Kim, Joon-Tae Kim, Joung-Ho Rha, Keun-Sik Hong, Min Uk Jang, Sang-Bae Ko, Sun U. Kwon대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제1호허혈성 뇌졸중 환자에서의 Thrombin Activable Fibrinolysis Inhibitor의 의의강성하, 강희정, 김영철, 박민정, 유경호, 이병철, 이영경, 조현찬대한진단검사의학회 · Annals of Laboratory Medicine2004 · 제24권 제6호2019 Update of the Korean Clinical Practice Guidelines of Stroke for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke강동훈, Byung-Chul Lee, Byung Moon Kim, Byung-Woo Yoon, Cheolkyu Jung, Hae Woong Jeong, Hee-Joon Bae, Hong-Kyun Park, Ji Hoe Heo, Jong S. Kim, Joung-Ho Rha, Keun-Sik Hong, Sang-Bae Ko, Sang Hyun Suh, Sun U. Kwon대한뇌졸중학회 · 대한뇌졸중영문학회지2019 · 제21권 제2호중증의 신경학적 증상을 동반하는 급성 경동맥계 허혈성 뇌졸중의 정맥내 rt-PA 혈전용해치료: 뇌졸중 성과에 대한 혈관 재개통의 의의신원철, 윤성상, 장대일, 정경천대한신경과학회 · 대한신경과학회지2003 · 제21권 제1호급성 뇌경색 환자의 증상 발현 후 응급실 도착까지의 시간이 치료 결과에 미치는 영향권영대, 윤성상, 장혜정대한예방의학회 · 예방의학회지2007 · 제40권 제2호

이 간행물의 다른 논문 (20건)